Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5913 | 1559 | 26.2 | 55% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
346 | 3 | CARDIOTOXICITY//ANTHRACYCLINES//CAMPTOTHECIN | 36072 |
2496 | 2 | IFOSFAMIDE//CHEMOSENSITIVITY TEST//MESNA | 3914 |
5913 | 1 | CHEMOSENSITIVITY TEST//HISTOCULTURE DRUG RESPONSE ASSAY//CHEMOSENSITIVITY | 1559 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CHEMOSENSITIVITY TEST | authKW | 565388 | 3% | 53% | 54 |
2 | HISTOCULTURE DRUG RESPONSE ASSAY | authKW | 204678 | 1% | 58% | 18 |
3 | CHEMOSENSITIVITY | authKW | 166967 | 7% | 8% | 102 |
4 | CHEMOSENSITIVITY ASSAY | authKW | 129589 | 1% | 44% | 15 |
5 | HISTOCULTURE | authKW | 110313 | 1% | 43% | 13 |
6 | COLLAGEN GEL DROPLET EMBEDDED CULTURE DRUG SENSITIVITY TEST | authKW | 105751 | 1% | 60% | 9 |
7 | CD DST | authKW | 104447 | 1% | 67% | 8 |
8 | CHEMORESPONSE ASSAY | authKW | 87236 | 0% | 64% | 7 |
9 | DRUG RESPONSE ASSAY | authKW | 78339 | 0% | 100% | 4 |
10 | IN VITRO CHEMOSENSITIVITY TEST | authKW | 78331 | 1% | 50% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 22726 | 62% | 0% | 963 |
2 | CYTOLOGY & HISTOLOGY | 557 | 1% | 0% | 15 |
3 | Obstetrics & Gynecology | 474 | 6% | 0% | 94 |
4 | Medicine, Research & Experimental | 232 | 6% | 0% | 89 |
5 | Surgery | 231 | 9% | 0% | 136 |
6 | Pharmacology & Pharmacy | 193 | 9% | 0% | 142 |
7 | Urology & Nephrology | 176 | 4% | 0% | 60 |
8 | Hematology | 122 | 4% | 0% | 55 |
9 | Otorhinolaryngology | 73 | 2% | 0% | 29 |
10 | Pathology | 37 | 2% | 0% | 33 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHEMOSENSITIVITATESTUNGEN | 58754 | 0% | 100% | 3 |
2 | MICHAEL DARMADY | 31331 | 0% | 40% | 4 |
3 | ANTITUMOR DRUG SENSIT TEST | 19585 | 0% | 100% | 1 |
4 | BIOCLIN UNIT | 19585 | 0% | 100% | 1 |
5 | CANC INTERNAL MED ROOM 3945 | 19585 | 0% | 100% | 1 |
6 | CELL BIOL DIAGNOST | 19585 | 0% | 100% | 1 |
7 | CLIN EPIDEMIOL DUKE COMPREHENS CANC | 19585 | 0% | 100% | 1 |
8 | DERALD H RUTTENBURG CANC NEOPLAST DIS | 19585 | 0% | 100% | 1 |
9 | DT PROGUSC CHLA PCR HO PEDIAT | 19585 | 0% | 100% | 1 |
10 | GENE DIAG GENE THER YCHUO KU | 19585 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF CELL CLONING | 40746 | 2% | 7% | 30 |
2 | RECENT RESULTS IN CANCER RESEARCH | 31378 | 2% | 6% | 29 |
3 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 11280 | 2% | 2% | 33 |
4 | BRITISH JOURNAL OF CANCER | 8383 | 6% | 0% | 88 |
5 | ANTICANCER RESEARCH | 6974 | 5% | 0% | 83 |
6 | EKSPERIMENTALNAYA ONKOLOGIYA | 5683 | 1% | 2% | 19 |
7 | ANTI-CANCER DRUGS | 5356 | 2% | 1% | 30 |
8 | ARCHIV FUR GESCHWULSTFORSCHUNG | 5217 | 1% | 3% | 10 |
9 | JAPANESE JOURNAL OF SURGERY | 4478 | 1% | 2% | 14 |
10 | CANCER TREATMENT REPORTS | 4265 | 1% | 1% | 22 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HOFFMAN, RM , (1993) IN-VITRO ASSAYS FOR CHEMOTHERAPY SENSITIVITY.CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY. VOL. 15. ISSUE 2. P. 99-111 | 94 | 81% | 15 |
2 | HOFFMAN, RM , (1991) INVITRO SENSITIVITY ASSAYS IN CANCER - A REVIEW, ANALYSIS, AND PROGNOSIS.JOURNAL OF CLINICAL LABORATORY ANALYSIS. VOL. 5. ISSUE 2. P. 133-143 | 87 | 82% | 73 |
3 | BUSSMANN, L , BUSCH, CJ , LORINCZ, BB , RIECKMANN, T , BLOCK, A , KNECHT, R , (2016) PERSPECTIVES IN CHEMOSENSITIVITY AND CHEMORESISTANCE ASSAYS AND THEIR IMPLEMENTATION IN HEAD AND NECK CANCER.EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. VOL. 273. ISSUE 12. P. 4073 -4080 | 29 | 73% | 0 |
4 | MONK, BJ , HERZOG, TJ , TEWARI, KS , (2016) EVOLUTION OF CHEMOSENSITIVITY AND RESISTANCE ASSAYS AS PREDICTORS OF CLINICAL OUTCOMES IN EPITHELIAL OVARIAN CANCER PATIENTS.CURRENT PHARMACEUTICAL DESIGN. VOL. 22. ISSUE 30. P. 4717 -4728 | 33 | 54% | 0 |
5 | VONHOFF, DD , (1988) HUMAN-TUMOR CLONING ASSAYS - APPLICATIONS IN CLINICAL ONCOLOGY AND NEW ANTINEOPLASTIC AGENT DEVELOPMENT.CANCER AND METASTASIS REVIEWS. VOL. 7. ISSUE 4. P. 357-371 | 49 | 80% | 57 |
6 | WEISENTHAL, LM , LIPPMAN, ME , (1985) CLONOGENIC AND NON-CLONOGENIC INVITRO CHEMOSENSITIVITY ASSAYS.CANCER TREATMENT REPORTS. VOL. 69. ISSUE 6. P. 615-632 | 58 | 66% | 197 |
7 | KITAOKA, A , MURAOKA, R , TANIGAWA, N , (1997) IMPROVEMENT OF IN VITRO CHEMOSENSITIVITY ASSAY FOR HUMAN SOLID TUMORS BY APPLICATION OF A PRECULTURE USING COLLAGEN MATRIX.CLINICAL CANCER RESEARCH. VOL. 3. ISSUE 2. P. 295-299 | 32 | 89% | 3 |
8 | LAU, V , WONG, ALA , NG, C , MOK, Y , LAKSHMANAN, M , YAN, B , (2016) DRUG SENSITIVITY TESTING PLATFORMS FOR GASTRIC CANCER DIAGNOSTICS.JOURNAL OF CLINICAL PATHOLOGY. VOL. 69. ISSUE 2. P. 93 -96 | 30 | 55% | 0 |
9 | HUH, JW , PARK, YA , LEE, KY , SOHN, SK , (2009) HETEROGENEITY OF ADENOSINE TRIPHOSPHATE-BASED CHEMOTHERAPY RESPONSE ASSAY IN COLORECTAL CANCER - SECONDARY PUBLICATION.YONSEI MEDICAL JOURNAL. VOL. 50. ISSUE 5. P. 697 -703 | 24 | 77% | 12 |
10 | CHOI, SK , JEONG, J , LEE, SA , HWANG, SH , AHN, SG , JUNG, WH , LEE, HD , (2010) HETEROGENEOUS CHEMOSENSITIVITY OF BREAST CANCER DETERMINED BY ADEONSINE TRIPHOSPHATE BASED CHEMOTHERAPY RESPONSE ASSAY.JOURNAL OF BREAST CANCER. VOL. 13. ISSUE 2. P. 180 -186 | 24 | 77% | 2 |
Classes with closest relation at Level 1 |